| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9305fc720f87097494d965f1b1310e24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-416 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-56 |
| filingDate |
2017-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_672ed4f4ece3285e65f5f325c850d48b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_183f647968cb127e9ccd4f8b0d91aed6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4156cd1af8ced2b171095615877c102c |
| publicationDate |
2019-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20190043013-A |
| titleOfInvention |
Novel indazole derivatives, and use thereof |
| abstract |
The present invention relates to a novel indazole derivative, or a pharmaceutically acceptable salt thereof; And a pharmaceutical composition for preventing or treating DYRK1A (Dual-specificity tyrosine phosphorylation-regulated kinase 1a) or DYRK1B-related diseases containing the same as an active ingredient. |
| priorityDate |
2017-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |